通过高度聚类调节异构糖氨酸受体功能的调节
bioRxiv : the preprint server for biology
|October 28, 2024
概括
与甘氨酸受体 (GlyRs) 一样,离子通道聚类会影响药物的疗效. 聚类增强了局部电荷,集中了连接体,并调节了潜在的止痛药开发的受体功能.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 离子通道是各种疾病的关键药物点.
- 离子通道聚类的功能影响仍然在很大程度上是未知的.
- 人类异构糖氨酸受体 (GlyRs) 是脊髓中的关键抑制受体,是疼痛治疗的点.
研究的目的:
- 为了研究聚类如何影响人类异构体GlyR功能.
- 确定GlyR聚类和功能调节的基础分子机制.
- 探索GlyR集群对慢性疼痛的治疗影响.
主要方法:
- 人类GlyRs (α2β) 的异质表达与gephyrin (GPHN) 和neuroligin-2 (NL2).
- 分析GlyR集群大小和度的显微镜技术.
- 生物化学测试以确定甘氨酸亲和力和配体结合动力学.
主要成果:
- 格莱尔α2β受体与GPHN形成微米大小的集群,由NL2.2进一步增强.
- 增加了GlyR度,而不是集群大小,单调地增加了明显的甘氨酸亲和力.
- 通过聚类来进行亲和度调制,GlyR β子单元的正电荷的N端是必不可少的.
- 对邻近的GlyRs的连接物重新结合改变了动力学,但没有改变平衡.
结论:
- 通过增强局部静电电位,缩离子和连接体来调节GlyR集群的功能.
- 这种由GlyR度和特定子单元序列驱动的机制,为离子通道行为提供了新的见解.
- 这些发现表明聚类离子通道的普遍机制对药物开发有影响,特别是对于慢性疼痛治疗.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
9.2K
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
G-protein Coupled Receptors
116.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
116.7K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
